Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

Immunotherapies are becoming increasingly important in the treatment armamentarium of a variety of malignancies. Immune checkpoint inhibitors are the most representative drugs receiving regulatory approval over the past few years. In a recent study published in Clinical Cancer Research, we demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardim, Denis L., de Melo Gagliato, Débora, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247554/
https://www.ncbi.nlm.nih.gov/pubmed/30229677
http://dx.doi.org/10.1177/1534735418801524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247554/
https://www.ncbi.nlm.nih.gov/pubmed/30229677
http://dx.doi.org/10.1177/1534735418801524

Ejemplares similares